411/420 Host Joya Mia Italiano discusses drug scheduling and the uproar of Cannabis being classed with harder “drugs”. Get “The Downlow on the Business of Getting High” by tuning into 411/420
Tune In To New Episodes of 411/420 Thursdays, Exclusively on Cashcroptoday.com
CashCropToday Media is a global media, branding and technology company, with a focus on news and information about investing, technology, entrepreneurship, and the lifestyle of Cannabis & Hemp.
Reaching more than 1.2 million people worldwide, CashCropToday offers news coverage focused on Investing in Cannabis & Hemp through public traded companies, political opinions, and documentary programming, 7 days a week.
Connect with CashCropToday
Find us on Facebook: https://www.facebook.com/cashcroptoday
Follow us on Twitter: https://twitter.com/cashcroptoday
Follow us on Instagram: https://www.instagram.com/cashcroptoday
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…